Assessment of elastin defcit in a Marfan mouse aneurysm model using an elastin-specifc magnetic resonance imaging contrast agent

Circulation: Cardiovascular Imaging

Volumn 7, Issue 4, 2014, Pages 690-696

  Okamura, Homare ^a,d   Pisani, Laura J ^b   Dalal, Alex R ^a   Emrich, Fabian ^a   Dake, Benjamin A ^a   Arakawa, Mamoru ^a,d   Onthank, David C ^e   Cesati, Richard R ^e   Robinson, Simon P ^e   Milanesi, Matteo ^f   Kotek, Gyula ^g   Smit, Henk ^g   Connolly, Andrew J ^c   Adachi, Hideo ^d   McConnell, Michael V ^b   Fischbein, Michael P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e Clinical Research   (United States)

^f AGILENT TECHNOLOGIES   (United Kingdom)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aortic aneurysm, thoracic; Magnetic resonance imaging; Marfan syndrome

Indexed keywords

1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; CHELATING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; ELASTIN; SINGLE HETEROCYCLIC RINGS; TETRAXETAN;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DISSECTING ANEURYSM; FEASIBILITY STUDY; MALE; MARFAN SYNDROME; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REPRODUCIBILITY; THORACIC AORTA; THORACIC AORTA ANEURYSM;

AORTIC ANEURYSM, THORACIC; MAGNETIC RESONANCE IMAGING; MARFAN SYNDROME;

ANEURYSM, DISSECTING; ANIMALS; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; CHELATING AGENTS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ELASTIN; FEASIBILITY STUDIES; HETEROCYCLIC COMPOUNDS, 1-RING; MAGNETIC RESONANCE IMAGING; MALE; MARFAN SYNDROME; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS;

EID: 84905818014     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.001658     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2010. CDC WONDER On-line Database. http://wonder.cdc.gov/cmf-icd10.html. Accessed on June 2, 2014.
2. Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150-e157.
3. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
4. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother. 2003;57:195-202.
5. Wight TN, Merrilees MJ. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res. 2004;94:1158-1167.
6. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res. 2001;88:37-43.
7. Perrone-Filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A. Molecular imaging of atherosclerosis in translational medicine. Eur J Nucl Med Mol Imaging. 2011;38:969-975.
8. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Monitoring plaque infammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Atherosclerosis. 2013;228:339-345.
9. Clough R, Taylor P. Future imaging techniques in aortic pathologies and clinical implications. J Cardiovasc Surg (Torino). 2013;54(1 suppl 1):15-19.
10. von Bary C, Makowski M, Preissel A, Keithan A, Warley A, Spuentrup E, Buecker A, Lazewatsky J, Cesati R, Onthank D, Schickl N, Schachoff S, Hausleiter J, Schömig A, Schwaiger M, Robinson S, Botnar R. MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ Cardiovasc Imaging. 2011;4:147-55.
11. Makowski MR, Wiethoff AJ, Blume U, Cuello F, Warley A, Jansen CH, Nagel E, Razavi R, Onthank DC, Cesati RR, Marber MS, Schaeffter T, Smith A, Robinson SP, Botnar RM. Assessment of atherosclerotic plaque burden with an elastin-specifc magnetic resonance contrast agent. Nat Med. 2011;17:383-388.
12. Allard M, Doucet D, Kien P, Bonnemain B, Caillé JM. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties. Invest Radiol. 1988;23(suppl 1):S271-S274.
13. Graves EE, Quon A, Loo BW Jr. RT-Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat. 2007;6:111-121.
14. Milanesi M, Barison A, Positano V, Masci PG, De Marchi D, Marinelli L, Hardy CJ, Foo TK, Landini L, Lombardi M. Modifed cine inversion recovery pulse sequence for the quantifcation of myocardial T1 and gadolinium partition coeffcient. J Magn Reson Imaging. 2013;37:109-118.
15. Smit H, Guridi RP, Guenoun J, Poot DH, Doeswijk GN, Milanesi M, Bernsen MR, Krestin GP, Klein S, Kotek G. T1 mapping in the rat myocardium at 7 tesla using a modifed CINE inversion recovery sequence. J Magn Reson Imaging. 2014;39:901-910.
16. Judge DP, Biery NJ, Keene DR, Geubtner J, Myers L, Huso DL, Sakai LY, Dietz HC. Evidence for a critical contribution of haploinsuff-ciency in the complex pathogenesis of Marfan syndrome. J Clin Invest. 2004;114:172-181.
17. Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res. 2012;110:312-324.
18. Kuivaniemi H, Platsoucas CD, Tilson MD 3rd. Aortic aneurysms: an immune disease with a strong genetic component. Circulation. 2008;117:242-252.
19. Makowski MR, Wiethoff A, Ebersberger U, Blume U, Warley A, Jansen C, Onthank DC, Cesati RR, Razavi R, Marber M, Schaeffer T, Robinson SP, Botner RM. Molecular assessment of aortic aneurysm wall integrity using an elastin-specifc MR imaging probe. J Cardiovasc Mag Reso. 2013;15:4.
20. Kaewlai R, Abujudeh H. Nephrogenic systemic fbrosis. AJR Am J Roentgenol. 2012;199:W17-W23.
21. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491-2499.
22. Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL. Imaging atherosclerosis and vulnerable plaque. J Nucl Med. 2010;51:51S-65S.